Biogen (NASDAQ: BIIB) reported Q1 EPS of $6.98, $0.14 better than the analyst estimate of $6.84. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.39 billion.

For earnings history and earnings-related data on Biogen (BIIB) click here.